GlobeNewsWire
27 Jun 2026, 00:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Accenture lowered its fiscal year 2026 revenue growth forecast to 3-4% from the previous 3-5% range. — A downward revision in full-year growth guidance directly lowers valuation expectations and signals slowing demand.
-0.60Morgan Stanley downgraded Accenture to 'Hold' and slashed its price target from $240 to $177. — A significant price target cut and rating downgrade from a major institutional broker often triggers systemic selling.
-0.50Kirby McInerney LLP is investigating Accenture for possible violations of federal securities laws following the guidance revision. — The threat of shareholder litigation introduces legal risk and potential future settlement costs.
-0.40Continue reading
6 related stories
Top 3 movers · tap to explore
Accenture's third quarter revenue of $18.7 billion missed analyst expectations of $18.78 billion. — Missing quarterly revenue estimates indicates a short-term failure to meet market expectations.
Which stocks this story touches
The company is facing a law firm investigation, a Morgan Stanley downgrade, and revised lower revenue growth forecasts.
Mentioned as the subject of a securities investigation by a plaintiffs' law firm.
Mentioned as the subject of a securities investigation by a plaintiffs' law firm.
Mentioned only as the source of a stock downgrade for another company.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
3h ago
